Extendicare Inc. (EXETF)
USD 10.51
(3.75%)
USD 10.51
(3.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 672.73 Million CAD | -13.93% |
| 2022 | 781.57 Million CAD | -13.19% |
| 2021 | 900.32 Million CAD | -6.52% |
| 2020 | 963.12 Million CAD | 8.36% |
| 2019 | 888.8 Million CAD | -0.84% |
| 2018 | 896.32 Million CAD | -4.06% |
| 2017 | 934.28 Million CAD | -5.5% |
| 2016 | 988.61 Million CAD | -3.73% |
| 2015 | 1.02 Billion CAD | -46.38% |
| 2014 | 1.91 Billion CAD | 3.58% |
| 2013 | 1.84 Billion CAD | 2.28% |
| 2012 | 1.8 Billion CAD | -1.24% |
| 2011 | 1.83 Billion CAD | 7.81% |
| 2010 | 1.69 Billion CAD | 1.8% |
| 2009 | 1.66 Billion CAD | -7.64% |
| 2008 | 1.8 Billion CAD | 25.4% |
| 2007 | 1.44 Billion CAD | 9.5% |
| 2006 | 1.31 Billion CAD | -22.55% |
| 2005 | 1.69 Billion CAD | 19.05% |
| 2004 | 1.42 Billion CAD | -10.49% |
| 2003 | 1.59 Billion CAD | -11.96% |
| 2002 | 1.8 Billion CAD | 4.0% |
| 2001 | 1.74 Billion CAD | 0.26% |
| 2000 | 1.73 Billion CAD | -5.36% |
| 1999 | 1.83 Billion CAD | -17.45% |
| 1998 | 2.22 Billion CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 706.33 Million CAD | 0.76% |
| 2024 Q1 | 701 Million CAD | 4.2% |
| 2023 Q2 | 764.93 Million CAD | 2.55% |
| 2023 Q4 | 672.73 Million CAD | -2.22% |
| 2023 Q1 | 745.88 Million CAD | -4.57% |
| 2023 FY | 672.73 Million CAD | -13.93% |
| 2023 Q3 | 687.99 Million CAD | -10.06% |
| 2022 Q4 | 781.57 Million CAD | 0.22% |
| 2022 FY | 781.57 Million CAD | -13.19% |
| 2022 Q1 | 901.14 Million CAD | 0.09% |
| 2022 Q3 | 779.86 Million CAD | -4.33% |
| 2022 Q2 | 815.12 Million CAD | -9.55% |
| 2021 Q2 | 908.06 Million CAD | -2.76% |
| 2021 Q3 | 909.06 Million CAD | 0.11% |
| 2021 Q4 | 900.32 Million CAD | -0.96% |
| 2021 Q1 | 933.79 Million CAD | -3.05% |
| 2021 FY | 900.32 Million CAD | -6.52% |
| 2020 Q4 | 963.12 Million CAD | 3.5% |
| 2020 FY | 963.12 Million CAD | 8.36% |
| 2020 Q3 | 930.55 Million CAD | 2.42% |
| 2020 Q2 | 908.59 Million CAD | 3.95% |
| 2020 Q1 | 874.04 Million CAD | -1.66% |
| 2019 Q1 | 888.63 Million CAD | -0.86% |
| 2019 FY | 888.8 Million CAD | -0.84% |
| 2019 Q2 | 898.19 Million CAD | 1.08% |
| 2019 Q3 | 900.19 Million CAD | 0.22% |
| 2019 Q4 | 888.8 Million CAD | -1.27% |
| 2018 Q1 | 921.17 Million CAD | -1.4% |
| 2018 Q3 | 914.15 Million CAD | 0.04% |
| 2018 Q4 | 896.32 Million CAD | -1.95% |
| 2018 FY | 896.32 Million CAD | -4.06% |
| 2018 Q2 | 913.79 Million CAD | -0.8% |
| 2017 Q2 | 954.21 Million CAD | -2.19% |
| 2017 Q4 | 934.28 Million CAD | -0.7% |
| 2017 FY | 934.28 Million CAD | -5.5% |
| 2017 Q1 | 975.62 Million CAD | -1.31% |
| 2017 Q3 | 940.83 Million CAD | -1.4% |
| 2016 Q2 | 944.45 Million CAD | -2.68% |
| 2016 FY | 988.61 Million CAD | -3.73% |
| 2016 Q4 | 988.61 Million CAD | 0.49% |
| 2016 Q3 | 983.81 Million CAD | 4.17% |
| 2016 Q1 | 970.45 Million CAD | -5.5% |
| 2015 Q1 | 2.01 Billion CAD | 5.25% |
| 2015 Q4 | 1.02 Billion CAD | -2.64% |
| 2015 Q3 | 1.05 Billion CAD | -51.34% |
| 2015 Q2 | 2.16 Billion CAD | 7.53% |
| 2015 FY | 1.02 Billion CAD | -46.38% |
| 2014 Q1 | 1.87 Billion CAD | 1.67% |
| 2014 FY | 1.91 Billion CAD | 3.58% |
| 2014 Q3 | 1.88 Billion CAD | 3.27% |
| 2014 Q4 | 1.91 Billion CAD | 1.61% |
| 2014 Q2 | 1.82 Billion CAD | -2.91% |
| 2013 Q1 | 1.82 Billion CAD | 1.14% |
| 2013 Q3 | 1.81 Billion CAD | -1.84% |
| 2013 Q4 | 1.84 Billion CAD | 2.11% |
| 2013 FY | 1.84 Billion CAD | 2.28% |
| 2013 Q2 | 1.84 Billion CAD | 0.89% |
| 2012 Q1 | 1.81 Billion CAD | -0.88% |
| 2012 Q3 | 1.86 Billion CAD | 2.92% |
| 2012 Q4 | 1.8 Billion CAD | -3.29% |
| 2012 FY | 1.8 Billion CAD | -1.24% |
| 2012 Q2 | 1.81 Billion CAD | 0.11% |
| 2011 Q3 | 1.96 Billion CAD | -0.23% |
| 2011 Q4 | 1.83 Billion CAD | -6.86% |
| 2011 FY | 1.83 Billion CAD | 7.81% |
| 2011 Q1 | 1.94 Billion CAD | 14.44% |
| 2011 Q2 | 1.97 Billion CAD | 1.38% |
| 2010 Q4 | 1.69 Billion CAD | -0.45% |
| 2010 Q3 | 1.7 Billion CAD | -2.75% |
| 2010 Q1 | 1.71 Billion CAD | 2.77% |
| 2010 Q2 | 1.75 Billion CAD | 2.31% |
| 2010 FY | 1.69 Billion CAD | 1.8% |
| 2009 Q3 | 1.65 Billion CAD | -3.76% |
| 2009 Q1 | 1.83 Billion CAD | 1.54% |
| 2009 Q2 | 1.71 Billion CAD | -6.21% |
| 2009 Q4 | 1.66 Billion CAD | 0.78% |
| 2009 FY | 1.66 Billion CAD | -7.64% |
| 2008 Q4 | 1.8 Billion CAD | 11.39% |
| 2008 Q1 | 1.49 Billion CAD | 4.03% |
| 2008 Q2 | 1.56 Billion CAD | 4.73% |
| 2008 Q3 | 1.62 Billion CAD | 3.34% |
| 2008 FY | 1.8 Billion CAD | 25.4% |
| 2007 FY | 1.44 Billion CAD | 9.5% |
| 2007 Q4 | 1.44 Billion CAD | 12.73% |
| 2007 Q3 | 1.27 Billion CAD | -4.05% |
| 2007 Q2 | 1.33 Billion CAD | 1.2% |
| 2007 Q1 | 1.31 Billion CAD | 0.03% |
| 2006 Q2 | 1.68 Billion CAD | -3.04% |
| 2006 Q3 | 1.75 Billion CAD | 3.92% |
| 2006 FY | 1.31 Billion CAD | -22.55% |
| 2006 Q1 | 1.73 Billion CAD | 2.41% |
| 2006 Q4 | 1.31 Billion CAD | -24.94% |
| 2005 Q3 | 1.69 Billion CAD | -4.05% |
| 2005 FY | 1.69 Billion CAD | 19.05% |
| 2005 Q1 | 1.74 Billion CAD | 22.6% |
| 2005 Q2 | 1.76 Billion CAD | 0.89% |
| 2005 Q4 | 1.69 Billion CAD | 0.32% |
| 2004 FY | 1.42 Billion CAD | -10.49% |
| 2004 Q4 | 1.42 Billion CAD | -1.98% |
| 2004 Q3 | 1.45 Billion CAD | -5.43% |
| 2004 Q2 | 1.53 Billion CAD | -3.58% |
| 2004 Q1 | 1.59 Billion CAD | 0.15% |
| 2003 Q4 | 1.59 Billion CAD | -2.99% |
| 2003 FY | 1.59 Billion CAD | -11.96% |
| 2003 Q1 | 1.7 Billion CAD | 0.0% |
| 2003 Q2 | 1.62 Billion CAD | -4.72% |
| 2003 Q3 | 1.64 Billion CAD | 1.04% |
| 2002 FY | 1.8 Billion CAD | 4.0% |
| 2001 FY | 1.74 Billion CAD | 0.26% |
| 2000 FY | 1.73 Billion CAD | -5.36% |
| 1999 FY | 1.83 Billion CAD | -17.45% |
| 1998 FY | 2.22 Billion CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| The Amacore Group, Inc. | 12.04 Million USD | -5484.777% |
| Arem Pacific Corporation | 259.81 Thousand USD | -258830.915% |
| Assisted 4 Living, Inc. | 264.81 Thousand USD | -253942.899% |
| BioCorRx Inc. | 388.88 Thousand USD | -172888.812% |
| Bionik Laboratories Corp. | 3.36 Million USD | -19909.089% |
| Banyan Corp. | 4.5 Million USD | -14839.867% |
| Clearday, Inc. | 33.75 Million USD | -1893.246% |
| Dental Patient Care America, Inc. | 2.24 Million USD | -29882.133% |
| Quantum Medical Transport, Inc. | 1298.56 USD | -51805823.484% |
| Empower Clinics Inc. | 2.96 Million USD | -22603.805% |
| First Choice Healthcare Solutions, Inc. | 3.12 Million USD | -21439.578% |
| Selectis Health, Inc. | 40.67 Million USD | -1554.062% |
| Ethema Health Corporation | 11.51 Million USD | -5740.097% |
| HealthLynked Corp. | 4.28 Million USD | -15617.5% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 93.12 Million USD | -622.362% |
| JRSIS Health Care Corporation | 2.14 Million USD | -31269.697% |
| Comjoyful International Company | 1.21 Million USD | -55133.11% |
| Medical Facilities Corporation | 353.06 Million USD | -90.538% |
| MedSmart Group Inc. | 751.69 Thousand USD | -89394.85% |
| North America Frac Sand, Inc. | 356.16 Thousand USD | -188780.248% |
| Nova Leap Health Corp. | 20.89 Million USD | -3119.467% |
| Nexteligent Holdings, Inc. | 446.95 Thousand USD | -150414.258% |
| PAO Group, Inc. | 575.00 USD | -116996595.652% |
| Primemd Inc. | 15.32 Million USD | -4290.055% |
| Raffles Medical Group Ltd | 1.15 Billion USD | 41.908% |
| Ryman Healthcare Limited | 7.82 Billion USD | 91.398% |
| Stem Cell Authority, Ltd. | 15.00 USD | -4484873233.333% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 7.22 Million USD | -9212.063% |
| Mycotopia Therapies, Inc. | 2.21 Million USD | -30211.213% |
| U.S. NeuroSurgical Holdings, Inc. | 1.32 Million USD | -50825.889% |
| Veltex Corporation | 1.8 Million USD | -37209.068% |
| World Financial Holding Group | 292.00 USD | -230387228.767% |
| Xcelerate Inc. | 1.91 Million USD | -34957.007% |